Hoth Therapeutics Stock (NASDAQ: HOTH) stock price, news, charts, stock research, profile.
Open | $1.140 |
Close | - |
Volume / Avg. | 18.882K / 434.186K |
Day Range | 1.140 - 1.160 |
52 Wk Range | 0.990 - 4.300 |
Market Cap | $5.671M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 5.12% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Hoth Therapeutics (NASDAQ: HOTH) through any online brokerage.
Other companies in Hoth Therapeutics’s space includes: Cingulate (NASDAQ:CING), 60 Degrees (NASDAQ:SXTP), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC) and Palisade Bio (NASDAQ:PALI).
The latest price target for Hoth Therapeutics (NASDAQ: HOTH) was reported by HC Wainwright & Co. on Friday, April 5, 2024. The analyst firm set a price target for 4.00 expecting HOTH to rise to within 12 months (a possible 244.86% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Hoth Therapeutics (NASDAQ: HOTH) is $1.1599 last updated Today at April 25, 2024 at 10:25 AM EDT.
There are no upcoming dividends for Hoth Therapeutics.
Hoth Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Hoth Therapeutics.
Hoth Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.